Efficacy and safety assessment of two schemes of oral administration of once-daily extended release metformin (metformin XR) in type 2 diabetic patients previously treated with metformin in combination with sulfonylurea. A 3-month, international, multicentre, randomised, double-blind, double-dummy, parallel group study.
Phase of Trial: Phase II
Latest Information Update: 26 Nov 2016
At a glance
- Drugs Metformin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 17 Jul 2012 New trial record